BNY Mellon Glbl Eq Inc Resp Inst W Acc
Global Equity IncomePricing frequency
Daily
Dealing cut off time
10:00
Type
OEIC
Yield
2.93%
NAV
£2.0529
Income frequency
Quarterly
Ongoing charge
0.83%
Latest actual NAV date
16-11-2026
ISIN
GB00BJ066Z75
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| BNY Mellon US Dollar Liquidity Adv Inc | 3.47 |
| Gilead Sciences Inc | 2.86 |
| AIA Group Ltd | 2.66 |
| Texas Instruments Inc | 2.49 |
| Elevance Health Inc | 2.37 |
| UnitedHealth Group Inc | 2.30 |
| GSK PLC | 2.28 |
| Smurfit WestRock PLC | 2.22 |
| Starbucks Corp | 2.14 |
| AstraZeneca PLC | 2.08 |
Investment objective
The Sub-Fund aims to achieve income together with the potential for capital growth over the long term (5 years or more). The Sub-Fund is actively managed and invests at least 75% of its NAV in equities (company shares) issued by companies located anywhere in the world (including ordinary shares, preference shares and other equity-related securities). At least 70% of the Sub-Fund’s NAV will meet the Investment Manager’s sustainability characteristics.